Insiders who reported open-market trades in the last 12 months at the companies A. Rachel Leheny files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Fred A. Middleton - $200K in CALC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
A. Rachel Leheny is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER, Director of CalciMedica, Inc. (CALC). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has A. Rachel Leheny submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has A. Rachel Leheny been buying or selling stock?
Recorded transactions: 3 open-market purchases ($85K) and 0 open-market sales across all tracked filings.
A. Rachel Leheny is CHIEF EXECUTIVE OFFICER, Director of CalciMedica, Inc. (CALC). 7 SEC Form 4 filings on record going back to 2024, most recently on 28 September 2026. Most recent open-market trade: bought $3K of CALC on 21 July 2025. Lifetime open-market purchases: $85K.
Recent transactions
4
The latest 4 SEC Form 4 transactions reported by A. Rachel Leheny.
InsiderAlpha's records for A. Rachel Leheny go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. The typical open-market purchase is $28K (3 buys totaling $85K). The largest single buy on record is $75K of CALC in 2024. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
